There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Kymera Therapeutics Inc. (KYMR) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $25.78. The Kymera Therapeutics Inc. has recorded 19,120 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary.
As a NASDAQ listed company, KYMR falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $25.78 and fluctuated between $25.82 as its day high and $24.39 as its day low. The current market capitalization of Kymera Therapeutics Inc. is $1.45B. A total of 0.51 million shares were traded on the day, compared to an average of 764.02K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, KYMR has seen 5 BUY and 24 SELL insider trades, representing the acquisition of 89,732 and the disposition of 1,017,436 shares. Over the last 12 months, there were 42 BUYs and 38 SELLs from insiders. Insiders purchased 1,763,759 shares during that period but sold 1,080,436.
In the most recent transaction, Booth Bruce sold 3,278 shares of KYMR for 30.00 per share on Dec 15. After the transaction, the Director now owns 917,811 company shares. In a previous transaction on Dec 15, Atlas Venture Fund X, L.P. sold 717 shares at 30.00 per share. KYMR shares that 10% Owner owns now total 917,811.
Among the insiders who sold shares, Atlas Venture Fund X, L.P. disposed of 2,561 shares on Dec 15 at a per-share price of $30.00. This resulted in the 10% Owner holding 5,066,925 shares of KYMR after the transaction. In another insider transaction, Atlas Venture Fund X, L.P. sold 82,889 shares at $31.37 per share on Dec 14. Company shares held by the 10% Owner now total 918,528.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for KYMR in the last 3 months, the mean price target is $55.63 with high estimates of $93.00 and low estimates of $31.00. In terms of 52-week highs and lows, KYMR has a high of $65.26 and a low of $13.15.
As of this writing, KYMR has an earnings estimate of -$0.74 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.44 per share and a lower estimate of -$1.03. The company reported an EPS of -$0.71 in the last quarter, which was -7.60% lower than expectations of -$0.66.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 18 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYMR is Underweight with a score of 4.29. A total of 12 analysts rated the stock as Buy while 0 rated it as Overweight while 6 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.